Pancreatic-enzyme treatment Pancreaze gains FDA approval

Deena Beasley- Reuters
The U.S. Food and Drug Administration on Monday approved Johnson & Johnson's (JNJ.N) Pancreaze, a pancreatic enzyme product used to improve food digestion in patients whose bodies do not produce enough of the enzymes.

Patients would include people with conditions such as cystic fibrosis, chronic pancreatitis, pancreatic tumors, or removal of all or a part of the pancreas, the agency said in a statement.

Two other companies have pancreatic enzyme products on the market -- Abbott Laboratories (ABT.N) and Eurand NV (EURX.O).

The FDA estimated that 200,000 or more patients in the United States need the enzyme products 

Note from Carolyn:
Mainstream medicine (patentable pharmacueticals) have jumped on the enzyme bandwagon. Did you now that plant based enzymes can do the same thing as this 'wonder drug' without the possible side effects or high cost? Check out the Enriching Gifts Plant Enzymes, and see how much your own health improves.     
(This information is not intended to serve as a prescription, or to diagnose, treat or replace the advice of your medical doctor. If you have any medical conditions or are taking prescription or non-prescription medications, consult your physician before altering or discounting the use of them.)